Avoid CapEX With Improved Operational Efficiencies: Helping To Expedite Quality Release Processes

Expanding a commercial product pipeline often hits a physical bottleneck at the warehouse door. When warehouse utilization exceeds 85% and sampling lead times balloon from one week to eight, the traditional response is a massive capital expenditure for new facilities. However, optimizing the supply chain through off-site sampling and managed inventory can eliminate the need for significant construction projects.
By delegating raw material sampling to a validated CGMP environment and utilizing just-in-time delivery, biopharmaceutical companies can bypass the multi-million dollar costs of building new cleanrooms and 30,000-square-foot warehouses. These operational shifts protect capital and streamline quality release processes to a single day. Download the full case study to see how strategic infrastructure choices impact speed to market.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.